Summary
This 2023 narrative review synthesises evidence on the relationship between gut microbiome composition and hypertension, as published in Nature Reviews Nephrology. The authors examine mechanistic pathways by which microbial taxa and their metabolic products influence blood pressure regulation, drawing on observational studies, animal models, and intervention trials. The review appears to propose the gut microbiota as a potentially modifiable factor in hypertension prevention and management, though specific clinical implications require further investigation.
Regional applicability
Findings on microbiota-hypertension links are relevant to UK clinical and public health policy, particularly given rising hypertension prevalence. However, applicability depends on whether mechanistic insights translate into dietary or probiotic interventions effective in UK populations with distinct baseline microbiota and dietary patterns.
Key measures
Gut microbiota composition, blood pressure, microbial metabolites (short-chain fatty acids, trimethylamine N-oxide), bacterial diversity and abundance, hypertension prevalence and incidence
Outcomes reported
The paper reviews evidence linking gut microbiota composition and function to the development and progression of hypertension. It examines potential mechanistic pathways through which microbial metabolites and bacterial taxa influence blood pressure regulation.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.